SEC Tracker
Get the app

Versant Venture Capital VII

Lycia Therapeutics, Inc. reports new ownership

Versant Ventures VII GP, L.P., new insider at Versant Venture Capital VII, L.P.

Form
3
Filed
Importance
Routine
  1. Versant Ventures VII GP, L.P. holds 25,390,410 common shares
  2. Versant Vantage II, L.P. holds 6,284,597 common shares
  3. Preferred stock convertible into common shares at 0.221793422 ratio

Written from the Form 3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Versant Venture Capital VII files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.